Skip to main content
SpringerLink
Log in

Epilepsy

  • Chapter
Controlled Clinical Trials in Neurological Disease

Part of the book series: Foundations of Neurology ((FONY,volume 1))

  • 106 Accesses

Abstract

More clinical trials may have been conducted in epilepsy than in any other neurologic disorder. The successful development of new antiepileptic drugs, the hope of finding yet a better medication, and the pecuniary potential of a new, effective, and less toxic drug have caused the literature to be filled with studies of putative antiepileptic compounds. The need is great. If the number of patients worldwide who suffer from epilepsy is near 50 million, one may assume that at least five million of these are poorly controlled and in need of better therapies. For most of these epileptic patients, hope lies in the discovery of new and better medications to control their seizures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gastaut H (1973). Dictionary of Epilepsy. Geneva: World Health Organization.

    Google Scholar 

  2. Porter RJ (1989). Epilepsy: 100 Elementary Principles, 2nd edition. London: Saunders.

    Google Scholar 

  3. Taylor J (1931). Selected Writings of John Hughlings Jackson, Vol. I: On Epilepsy and Epileptiform Convulsions. London: Hodder and Stoughton. Reprinted 1958, New York: Basic Books.

    Google Scholar 

  4. Gastaut H (1970). Clinical and electroencephalographic classification of epileptic seizures. Epilepsia 11:102–113.

    Article  PubMed  CAS  Google Scholar 

  5. Commission on Classification and Terminology of the International League Against Epilepsy (1981). Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489–501.

    Article  Google Scholar 

  6. Gastaut H, Broughton R (1972). Epileptic Seizures: Clinical and Electrographic Features, Diagnosis and Treatment. Springfield, IL: Charles C. Thomas.

    Google Scholar 

  7. Penry JK, Dreifuss FE (1969). Automatisms associated with the absence of petit mal epilepsy. Arch of Neurol 21:142–149.

    CAS  Google Scholar 

  8. Penry JK, Porter RJ, Dreifuss FE (1975). Simultaneous recording of absence seizures with videotape and electroencephalography: A study of 374 seizures in 48 patients. Brain 98: 427–440.

    Article  PubMed  CAS  Google Scholar 

  9. Holmes GL, McKeever M, Adamson M (1987). Absence seizures in children: Clinical and electroencephalographic features. Ann Neurol 21:268–273.

    Article  PubMed  CAS  Google Scholar 

  10. Porter RJ, Pitlick WH (1989). Antiepileptic drugs. In Katzung BG (ed.), Basic and Clinical Pharmacology, 4th edition. Norwalk, CT: Appelton & Lange, pp. 287–303.

    Google Scholar 

  11. Swinyard EA (1982). Introduction. In Woodbury DM, Penry JK, Pippenger CE (eds.), Antiepileptic Drugs, 2nd edition. New York: Raven Press, pp. 1–9.

    Google Scholar 

  12. Porter RJ, Nadi NS (1987). Investigations in the pharmacotherapy of the focal epilepsies. In Weiser HG, Speckman EH, Engel J (eds.) The Epileptic Focus. London: John Libbey, pp. 175–191.

    Google Scholar 

  13. Porter RJ, Cereghino JJ, Gladding GD, et al. (1984). Antiepileptic drug development program. Cleve Clin Q 51:293–305.

    PubMed  CAS  Google Scholar 

  14. Porter RJ (1988). New antiepileptic drugs: Prospects for improved treatment of seizures. In Pedley TA, Meldrum BS (eds.), Recent Advances in Epilepsy, Vol. 4. London: Churchill Livingstone, pp. 161–179.

    Google Scholar 

  15. Meldrum BS (1986). Pharmacological approaches to the treatment of epilepsy. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 17–30.

    Google Scholar 

  16. Porter RJ (1986). Clinical trials relating to epilepsy. In Poeck K, Freund HJ, Ganshirt H (eds.), Proceedings of the 13th World Congress of Neurology. Berlin: Springer-Verlag, pp. 305–312.

    Google Scholar 

  17. Mattson RH, Cramer JA, Collins JF, et al. (1985). Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 313:145–151.

    Article  PubMed  CAS  Google Scholar 

  18. Cereghino JJ, Penry JK (1982). Testing of antiepileptic drugs in humans: Clinical considerations. In Woodbury DM, Penry JK, Pippenger CE (eds.), Antiepileptic Drugs, 2nd edition. New York: Raven Press, pp. 141–157.

    Google Scholar 

  19. Sato S, White BG, Penry JK, et al. (1982). Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 32:157–163.

    PubMed  CAS  Google Scholar 

  20. Chalmers TC, Celano P, Sacks HS, et al. (1983). Bias in treatment assignment in controlled clinical trials. N Engl J Med 309:1358–1361.

    Article  PubMed  CAS  Google Scholar 

  21. Kurtzke JF (1986). Neuroepidemiology: Assessment of therapeutic trials. Ann Neurol 19: 311–319.

    Article  PubMed  CAS  Google Scholar 

  22. Meldrum BS, Porter RJ (eds.) (1986). New Anticonvulsant Drugs. London: John Libbey.

    Google Scholar 

  23. Leppik I (in press). Felbamate. Epilepsia.

    Google Scholar 

  24. Theodore WH (in press). Felbamate. Epilepsia.

    Google Scholar 

  25. Perhach JL, Weliky I, Newton JJ, et al. (1986). Felbamate. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 117–123.

    Google Scholar 

  26. Vanden Bussche G, Wauquier A, Aston D, et al. (1986). Flunarizine. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 125–133.

    Google Scholar 

  27. Bartoszyk GD, Meyerson N, Reimann W, et al. (1986). Gabapentin. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 147–163.

    Google Scholar 

  28. Crawford P, Ghadiali E, Lane R, et al. (1987). Gabapentin as an antiepileptic drug in man. J Neurol Neurosurg Psychiatry 50:682–686.

    Article  PubMed  CAS  Google Scholar 

  29. Porter RJ (in press). Substances under clinical development. In Dam M, Gram L (eds.), Epileptology: An International Perspective. New York: Raven Press.

    Google Scholar 

  30. Miller AA, Sawyer DA, Roth B, et al. (1986). Lamotrigine. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 165–177.

    Google Scholar 

  31. Roba J, Cavalier R, Cordi A, et al. (1986). Milacemide. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 179–190.

    Google Scholar 

  32. Norton LC, Laxer KD, Schomer D, et al. (1986). Phase II study to evaluate the efficacy and safety of milacemide (CP 1552S) in the treatment of complex partial seizures in adult patients. Epilepsia 27:648.

    Google Scholar 

  33. Troupin AS, Mendius JR, Cheng F, et al. (1986). MK-801. In Meldrum BS, Porter RJ (eds.), New Anticonvulant Drugs. London: John Libbey, pp. 191–201.

    Google Scholar 

  34. Wong EHF, Knight AR, Woodruff GN (1988). [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274–281.

    Article  PubMed  CAS  Google Scholar 

  35. de Graaff JS, Redpath J, Sam AP, et al. (1986). Org 6370. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 215–227.

    Google Scholar 

  36. Gram L, Philbert A (1986), Oxcarbazepine. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 229–235.

    Google Scholar 

  37. Morselli PL, Bartholini G, Lloyd KG (1986). Progabide. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 237–253.

    Google Scholar 

  38. Vincent JC (1986). Stiripentol. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 255–263.

    Google Scholar 

  39. Schechter PJ (1986). Vigabatrin. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 265–275.

    Google Scholar 

  40. Taylor CP, McLean JR, Bockbrader HN, et al. (1986). Zonisamide: AD-810, CI-912. In Meldrum BS, Porter RJ (eds.), New Anticonvulsant Drugs. London: John Libbey, pp. 277–294.

    Google Scholar 

Download references

Authors
  1. Roger J. Porter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

    Roger J. Porter  & Bruce S. Schoenberg  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Porter, R.J. (1990). Epilepsy. In: Porter, R.J., Schoenberg, B.S. (eds) Controlled Clinical Trials in Neurological Disease. Foundations of Neurology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1495-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1495-0_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8804-6

  • Online ISBN: 978-1-4613-1495-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation